Concord Biotech Limited (NSE: CONCORDBIO)
India flag India · Delayed Price · Currency is INR
2,151.05
+15.15 (0.71%)
Dec 24, 2024, 3:30 PM IST

Concord Biotech Revenue

Concord Biotech had revenue of 3.10B INR in the quarter ending September 30, 2024, with 18.23% growth. This brings the company's revenue in the last twelve months to 10.86B, up 11.88% year-over-year. In the fiscal year ending March 31, 2024, Concord Biotech had annual revenue of 10.17B with 19.20% growth.

Revenue (ttm)
10.86B
Revenue Growth
+11.88%
P/S Ratio
20.72
Revenue / Employee
7.88M
Employees
1,377
Market Cap
225.03B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202410.17B1.64B19.20%
Mar 31, 20238.53B1.40B19.67%
Mar 31, 20227.13B959.91M15.56%
Mar 31, 20216.17B1.05B20.42%
Mar 31, 20205.12B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition